It is important to note that AKT1 and SMO mutations are selectively observed in a subset of non-NF2-mutated meningiomas (9% and 6% of cases, respectively); furthermore, PIK3CA mutations occurred in 7% of non-NF2-mutant meningiomas [207]. Here, SMO is linked to meningioma.